Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept Therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|1|63-73

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.1, 2015-01, pp. : 63-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 194-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subcutaneous abatacept for the treatment of rheumatoid arthritis

By Schiff Michael  

British Journal of Rheumatology , Vol. 52, Iss. 6, 2013-06 ,pp. : 986-997

Oxford University Press

Access to resources Recommend Favorite

Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease‐modifying anti‐rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 4, 2015-05 ,pp. : 421-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

Galectin‐3, A Potential Therapeutic Target For Rheumatoid Arthritis?

By  

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (ELECTRONIC), Vol. 87, Iss. 2, 2018-02 ,pp. : 108-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Report: Expression of Interferon‐γ Receptor Genes in Peripheral Blood Mononuclear Cells Is Associated With Rheumatoid Arthritis and Its Radiographic Severity in African Americans

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 5, 2015-05 ,pp. : 1165-1170

John Wiley & Sons Inc

Access to resources Recommend Favorite